The Oklahoma Center for the Advancement of Science and Technology will provide $1.6 million to fund seven research projects
Each of the successful applicants will conduct research under this round of funding for two years.
OCAST received 28 proposals, and external reviewers recommended 16 for funding. But available funds allowed support only of the highest ranked seven projects.
Funded projects include research into optics and photonics, animal and plant biotechnology, semiconductors, biotechnology and diagnostics and therapeutic environmental biotechnology.
The funds are administered by OCAST through the Oklahoma Applied Research Support (OARS) program and represent a long-term effort by the state of Oklahoma to encourage technology-based economic development.
The recipients include:
• Terry Golding, of Amethyst Research Inc. in Ardmore, who received $300,000 to assist in his attempts to develop cost-effective manufacturing processes for ultrahigh-efficiency solar cells.
• Khalid Hossain, of Amethyst Research Inc. in Ardmore, who received $300,000 to develop the next-generation materials for solar cells through research into antimonide-based quantum dots.
• Ronald Wassel, Charlesson LLC of Oklahoma City, who got $300,000 to develop a manufacturing process for biodegradable microparticles for sustained drug delivery to the eye.
• Sean Bauman, Immuno-Mycologics Inc. of Norman, who was awarded $300,000 to research a method of early diagnosis of valley fever using serum or urine samples.
• Lucas Phinney, of Amethyst Research Inc. in Ardmore, who received $253,663 to conduct research into ways of reducing defects and lowering costs in the manufacture of infrared sensors and focal plane arrays.
• Guolong Zhang, of Oklahoma State University in Stillwater, awarded $90,000 to examine alternative dietary supplements that boost host immunity and disease resistance.
• John Quinn, SensiQ Technologies Inc. in Oklahoma City, who was awarded $90,000 to develop a new screening platform in the life science market for use by large pharmaceutical and biotech companies.